
What Are the ASCCP Guidelines? | Cervical Cancer Screening
The ASCCP Guidelines provide evidence-based recommendations for cervical cancer screening, HPV testing, and management of abnormal results. Explore current algorithms, clinical …
HHS Updates Cervical Cancer Screening Guidelines
3 days ago · The U.S. Health Research and Services Administration (HRSA), a division of the U.S. Department of Health and Human Services, released updated cervical cancer screening …
Discuss special populations and considerations for screening outside the typical screening. Apply management strategies for abnormal pap and HPV results by using the ASCCP application. …
Enduring Consensus Cervical Cancer Screening and Management Guidelines
The Enduring Consensus Cervical Cancer Screening and Management Guidelines is a process to provide regular updates to the 2019 ASCCP Risk-Based Management Consensus Guidelines …
New Cervical Cancer Screening Guidelines Strengthen Women’s …
Jan 5, 2026 · The Health Resources and Services Administration (HRSA) announced updated cervical cancer screening guidelines that include a new option for women to self-collect …
Updated Cervical Cancer Screening Guidelines - ACOG
The adoption of the USPSTF guidelines expands the recommended options for cervical cancer screening in average-risk individuals aged 30 years and older to include screening every 5 …
Management Guidelines - American Society for Colposcopy and ... - ASCCP
Risk-based Management Guidelines for abnormal screening results, including post-colposcopy or post-treatment scenarios. Enduring Guidelines apply this approach to new technologies that …
Updates in Cervical Cancer Screening: A Practical Guide for the ...
Jan 9, 2026 · The practical application of the ASCCP’s cervical cancer management guidelines in internal medicine primary care is to use a risk-based approach. The ASCCP guidelines are …
ASCCP Management Guidelines for Abnormal Cervical Cancer …
The ASCCP guidelines help determine the risk of developing cervical intraepithelial neoplasia grade 3 or worse (CIN3+), including CIN3, adenocarcinoma in situ, and invasive cervical …
• Allow updates to incorporate new test methods as they are validated, and to adjust for decreasing CIN3+ risks as more patients who received HPV vaccination reach screening age • …